HCM gains on GSK licensing; SNOW and NTSK also rise premarket
HCM rose +12% premarket on a licensing agreement with GSK. SNOW is up +24% and NTSK up +13% on earnings.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.